Overview
Nisia Lima practices practicing medicine in Rio De Janeiro, Brazil.
Their clinical expertise encompasses COVID-19, Dengue Fever, Severe Acute Respiratory Syndrome (SARS), and Viral Hemorrhagic Fever.
They are actively involved in clinical research, co-authoring 27 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Nisia T. Lima
Is Nisia T. Lima a top-rated expert for COVID-19?
MediFind is an objective health platform that identifies experts based on real-world data. Nisia T. Lima is classified as an Experienced expert for COVID-19, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Nisia T. Lima participate in research or clinical trials?
Yes. Nisia T. Lima has published 27 articles and abstracts on conditions like COVID-19. You can view a list of Nisia T. Lima's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Chagas DiseaseLima isExperienced. Learn about Chagas Disease.
- COVID-19Lima isExperienced. Learn about COVID-19.
- Dengue FeverLima isExperienced. Learn about Dengue Fever.
- Severe Acute Respiratory Syndrome (SARS)
- Viral Hemorrhagic FeverLima isExperienced. Learn about Viral Hemorrhagic Fever.